Ark. Code Ann. § 20-13-1803: Definitions

As used in this subchapter: (1) "Emergency medical services technician" means an individual licensed by the Department of Health at any level established by the rules adopted by the State Board of Health under § 20-13-301 et seq. and authorized to perform emergency medical services, including without limitation an EMT, Advanced EMT, paramedic, EMS Instructor, or EMS Instructor Trainer; (2) "First responders" means state and local law enforcement personnel, fire department personnel, and emergency medical personnel who will be deployed to bioterrorism attacks, terrorist attacks, catastrophic or natural disasters, and emergencies; (3) "Harm reduction organization" means an organization that provides direct assistance and services such as syringe exchanges, counseling, homeless services, advocacy, and drug treatment and screening to individuals at risk of experiencing a drug overdose; (4) "Healthcare professional" means a person or entity that is licensed, certified, or otherwise authorized by the laws of this state to administer health care in the ordinary course of the practice of his or her profession or as a function of an entity's administration of the practice of medicine; (5) "Opioid" means a drug or medication that relieves pain, including without limitation: (A) Hydrocodone; (B) Oxycodone; (C) Morphine; (D) Codeine; (E) Heroin; and (F) Fentanyl; (6) "Opioid antagonist" means any drug that binds to opioid receptors and blocks or inhibits the effects of opioids acting on the receptors and that is approved by the United States Food and Drug Administration for the treatment of an opioid-related drug overdose; and (7) "Opioid-related drug overdose" means an acute condition resulting from, or that a reasonable person would believe to be resulting from, the consumption or use of an opioid or another substance with which an opioid was combined by an individual with signs and symptoms that include without limitation: (A) Extreme physical illness; (B) Decreased level of consciousness; (C) Respiratory depression; (D) Coma; (E) Mania; or (F) Death. Added by Act 2015, No. 1222,§ 2, eff. 7/22/2015.

As used in this subchapter:

(1) "Emergency medical services technician" means an individual licensed by the Department of Health at any level established by the rules adopted by the State Board of Health under § 20-13-301 et seq. and authorized to perform emergency medical services, including without limitation an EMT, Advanced EMT, paramedic, EMS Instructor, or EMS Instructor Trainer;

(2) "First responders" means state and local law enforcement personnel, fire department personnel, and emergency medical personnel who will be deployed to bioterrorism attacks, terrorist attacks, catastrophic or natural disasters, and emergencies;

(3) "Harm reduction organization" means an organization that provides direct assistance and services such as syringe exchanges, counseling, homeless services, advocacy, and drug treatment and screening to individuals at risk of experiencing a drug overdose;

(4) "Healthcare professional" means a person or entity that is licensed, certified, or otherwise authorized by the laws of this state to administer health care in the ordinary course of the practice of his or her profession or as a function of an entity's administration of the practice of medicine;

(5) "Opioid" means a drug or medication that relieves pain, including without limitation: (A) Hydrocodone; (B) Oxycodone; (C) Morphine; (D) Codeine; (E) Heroin; and (F) Fentanyl;

(A) Hydrocodone;

(B) Oxycodone;

(C) Morphine;

(D) Codeine;

(E) Heroin; and

(F) Fentanyl;

(6) "Opioid antagonist" means any drug that binds to opioid receptors and blocks or inhibits the effects of opioids acting on the receptors and that is approved by the United States Food and Drug Administration for the treatment of an opioid-related drug overdose; and

eine; (E) Heroin; and (F) Fentanyl;

(A) Hydrocodone;

(B) Oxycodone;

(C) Morphine;

(D) Codeine;

(E) Heroin; and

(F) Fentanyl;

(6) "Opioid antagonist" means any drug that binds to opioid receptors and blocks or inhibits the effects of opioids acting on the receptors and that is approved by the United States Food and Drug Administration for the treatment of an opioid-related drug overdose; and

(7) "Opioid-related drug overdose" means an acute condition resulting from, or that a reasonable person would believe to be resulting from, the consumption or use of an opioid or another substance with which an opioid was combined by an individual with signs and symptoms that include without limitation: (A) Extreme physical illness; (B) Decreased level of consciousness; (C) Respiratory depression; (D) Coma; (E) Mania; or (F) Death.

(A) Extreme physical illness;

(B) Decreased level of consciousness;

(C) Respiratory depression;

(D) Coma;

(E) Mania; or

(F) Death.